Characteristics | Value (n = 95) | |
---|---|---|
Age (mean years ± S.D.) | 62.1 ± 12.0 | |
Gender (n, male/female) | 54/41 | |
Body surface area (m2, mean ± S.D.) | 1.57 ± 0.17 | |
Concomitant use of 5-FU drugsa) (n, Y/N) | 33/62 | |
Hemoglobin at the start of administration (mean g/dL ± S.D.) | 11.2 ± 1.8 | |
Primary site | ||
Stomach, n (%) | 32 | (33.7) |
Breast, n (%) | 23 | (24.2) |
Lung, n (%) | 19 | (20.0) |
Prostatic, n (%) | 9 | (9.5) |
Others, n (%) | 12 | (12.6) |